Rural Health
Resources by Topic: Illicit drug use
Controlled Substance Prescribing Patterns Among Fatal Overdose Decedents with an Opioid, Stimulant, or Both Contributing to Death — Pennsylvania, 2017–2022
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
The Rural and Urban Supply of Clinicians With a DEA Waiver to Prescribe Buprenorphine in 2022 Prior to the Elimination of the Waiver Requirement
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Synthetic Opioid and Stimulant Co-Involved Overdose Deaths by Occupation and Industry — United States, 2022
Examines occupations and industries with higher percentages of psychostimulant involvement in synthetic opioid overdose deaths. Includes information on occupations such as mining and farming, fishing, and forestry that are more common in rural areas.
Author(s): Eric W. Lundstrom, Alexandria Macmadu, Andrea L. Steege, Matthew Groenewold
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(10), 173–178
Date: 03/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Examines occupations and industries with higher percentages of psychostimulant involvement in synthetic opioid overdose deaths. Includes information on occupations such as mining and farming, fishing, and forestry that are more common in rural areas.
Author(s): Eric W. Lundstrom, Alexandria Macmadu, Andrea L. Steege, Matthew Groenewold
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(10), 173–178
Date: 03/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Enhancing Rural Access to Medications for Opioid Use Disorder: Policy Brief and Recommendations to the Secretary
Provides an overview of issues related to opioid use disorder (OUD) in rural areas. Discusses access to medication for opioid use disorder (MOUD), MOUD workforce, telehealth to support access to MOUD, and Medicaid 1115 demonstrations that address OUD. Offers policy recommendations related to regulatory barriers, reimbursement flexibility, workforce, and service site expansion to increase access to MOUD in rural areas.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Provides an overview of issues related to opioid use disorder (OUD) in rural areas. Discusses access to medication for opioid use disorder (MOUD), MOUD workforce, telehealth to support access to MOUD, and Medicaid 1115 demonstrations that address OUD. Offers policy recommendations related to regulatory barriers, reimbursement flexibility, workforce, and service site expansion to increase access to MOUD in rural areas.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Assessing the Needs of Rural Families Affected by the Opioid Crisis: Issue Brief and Recommendations to the Secretary
Explores the considerations for addressing social determinants of health that influence opioid use disorder (OUD) and the role of community efforts in prevention, treatment, and recovery in rural areas, with a focus on prevention efforts in Las Vegas, New Mexico. Discusses youth and family prevention and well-being; stigma; adverse childhood experience; school-based health centers and youth and family resource centers; access to stable housing, food, and other social supports; the importance of trusted community resources for support; and workforce. Offers recommendations related to reducing stigma and promoting the enhanced utilization of the Community Services Block Grant (CSBG) to help rural communities address OUD and substance use disorders.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Explores the considerations for addressing social determinants of health that influence opioid use disorder (OUD) and the role of community efforts in prevention, treatment, and recovery in rural areas, with a focus on prevention efforts in Las Vegas, New Mexico. Discusses youth and family prevention and well-being; stigma; adverse childhood experience; school-based health centers and youth and family resource centers; access to stable housing, food, and other social supports; the importance of trusted community resources for support; and workforce. Offers recommendations related to reducing stigma and promoting the enhanced utilization of the Community Services Block Grant (CSBG) to help rural communities address OUD and substance use disorders.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit
Provides planning and strategy resources for organizations and communities to expand access to naloxone and other opioid overdose reversal medications (OORMs). Includes templates, implementation strategies and program examples, and more. Discusses rural considerations and programs throughout, including the Rural EMS Training Program and Rural Communities Opioid Response Program (RCORP).
Date: 01/2025
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Provides planning and strategy resources for organizations and communities to expand access to naloxone and other opioid overdose reversal medications (OORMs). Includes templates, implementation strategies and program examples, and more. Discusses rural considerations and programs throughout, including the Rural EMS Training Program and Rural Communities Opioid Response Program (RCORP).
Date: 01/2025
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
A Rural-Urban Analysis of Buprenorphine Therapy During and After Pregnancy Among the Commercially Insured
Explores the use of evidence-based buprenorphine treatment and adherence during the peri-pregnancy period among commercially insured individuals by rurality. Analyzes data on 1,331,040 people between 15 and 44 years-old with diagnosis codes for pregnancy and labor/delivery from January 1, 2015, to December 31, 2019.
Author(s): KariLynn Dowling-McClay, Bill Brooks, Daniel Krauss, et al.
Date: 01/2025
Sponsoring organization: ETSU/NORC Rural Health Research Center
view details
Explores the use of evidence-based buprenorphine treatment and adherence during the peri-pregnancy period among commercially insured individuals by rurality. Analyzes data on 1,331,040 people between 15 and 44 years-old with diagnosis codes for pregnancy and labor/delivery from January 1, 2015, to December 31, 2019.
Author(s): KariLynn Dowling-McClay, Bill Brooks, Daniel Krauss, et al.
Date: 01/2025
Sponsoring organization: ETSU/NORC Rural Health Research Center
view details
Patient Centered Medication Treatment for Opioid Use Disorder in Rural Vermont: A Qualitative Study
Examines patient perspectives on medications for opioid use disorder (MOUD) treatment in rural Vermont, utilizing interview data from 15 people who received care at Vermont Hub and Spoke clinics. Highlights patient perspectives on aspects of patient-centered care, and their influences on retention and engagement with treatment.
Author(s): Emily G. Hichborn, Owen B. Murray, Eilis I. Murphy, et al.
Citation: Addiction Science & Clinical Practice, 20, 3
Date: 01/2025
view details
Examines patient perspectives on medications for opioid use disorder (MOUD) treatment in rural Vermont, utilizing interview data from 15 people who received care at Vermont Hub and Spoke clinics. Highlights patient perspectives on aspects of patient-centered care, and their influences on retention and engagement with treatment.
Author(s): Emily G. Hichborn, Owen B. Murray, Eilis I. Murphy, et al.
Citation: Addiction Science & Clinical Practice, 20, 3
Date: 01/2025
view details
Cannabis Use Characteristics and Associations with Problematic Use Outcomes, Quitting-Related Factors, and Mental Health among US Young Adults
Examines factors related to cannabis use via latent class analysis of survey data provided by 4,031 young adults. Includes data on frequency of use, problematic use, quitting, and mental health, with data breakdowns by rural, suburban/micropolitan, and urban dwelling.
Author(s): Carla J. Berg, Cassidy R. LoParco, Katelyn F. Romm, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 20, 1
Date: 01/2025
view details
Examines factors related to cannabis use via latent class analysis of survey data provided by 4,031 young adults. Includes data on frequency of use, problematic use, quitting, and mental health, with data breakdowns by rural, suburban/micropolitan, and urban dwelling.
Author(s): Carla J. Berg, Cassidy R. LoParco, Katelyn F. Romm, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 20, 1
Date: 01/2025
view details
Implementation of Mobile Medication Units: Findings from a Qualitative Study
Provides a brief overview of the development of policy regarding the approval of mobile medication units (MMUs) operated by opioid treatment programs (OTPs). Presents findings from an environmental scan and key informant interviews regarding MMU implementation. Discusses barriers to establishing, sustaining, and expanding MMU services. Describes opportunities to increase access to methadone in underserved communities. Includes rural references throughout.
Date: 01/2025
Sponsoring organizations: HHS Office of the Assistant Secretary for Planning and Evaluation, Mathematica
view details
Provides a brief overview of the development of policy regarding the approval of mobile medication units (MMUs) operated by opioid treatment programs (OTPs). Presents findings from an environmental scan and key informant interviews regarding MMU implementation. Discusses barriers to establishing, sustaining, and expanding MMU services. Describes opportunities to increase access to methadone in underserved communities. Includes rural references throughout.
Date: 01/2025
Sponsoring organizations: HHS Office of the Assistant Secretary for Planning and Evaluation, Mathematica
view details